| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.289 | 18.812 | 20.397 | 37.937 | 47.695 | 40.711 | 33.337 | 33.186 | 53.243 | 42.514 |
| Total Income - EUR | 22.290 | 18.812 | 20.398 | 37.937 | 47.696 | 40.711 | 34.853 | 33.186 | 56.746 | 43.936 |
| Total Expenses - EUR | 17.569 | 18.256 | 12.943 | 24.544 | 30.739 | 26.137 | 28.697 | 32.264 | 44.865 | 43.295 |
| Gross Profit/Loss - EUR | 4.720 | 556 | 7.454 | 13.393 | 16.957 | 14.574 | 6.156 | 922 | 11.881 | 641 |
| Net Profit/Loss - EUR | 4.052 | -8 | 6.842 | 12.617 | 15.526 | 13.451 | 5.276 | 201 | 11.398 | 277 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Lyana Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 183 | 22 | 0 | 0 | 12.108 | 10.437 | 20.977 | 12.914 | 6.354 | 2.348 |
| Current Assets | 20.598 | 13.502 | 16.846 | 23.474 | 30.217 | 36.986 | 43.331 | 37.516 | 22.415 | 20.856 |
| Inventories | 11.791 | 6.941 | 7.324 | 7.782 | 11.079 | 11.887 | 14.845 | 15.347 | 14.561 | 15.446 |
| Receivables | 977 | 3.408 | 1.751 | 1.464 | 2.797 | 1.447 | 2.295 | 4.289 | 3.746 | 3.212 |
| Cash | 7.829 | 3.153 | 7.770 | 14.229 | 16.341 | 23.653 | 26.191 | 17.879 | 4.109 | 2.198 |
| Shareholders Funds | 6.957 | 6.877 | 13.603 | 22.351 | 37.445 | 45.833 | 50.093 | 38.710 | 49.990 | 49.987 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.825 | 6.670 | 3.245 | 1.123 | 4.880 | 1.589 | 14.216 | 11.720 | 9.193 | 5.967 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Lyana Lab S.r.l.